Evidence map›Paper›PMID 29404848›Full record

ArticleAnnals of biomedical engineering2018

Eliminating Regurgitation Reduces Fibrotic Remodeling of Functional Mitral Regurgitation Conditioned Valves.

Patrick S Connell, Dragoslava P Vekilov, Christine M Diaz, Seulgi E Kim, K Jane Grande-Allen

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick S ConnellDepartment of Bioengineering, Rice University, 6100 Main St., MS 142, Houston, TX, 77005, USA.
Dragoslava P VekilovDepartment of Bioengineering, Rice University, 6100 Main St., MS 142, Houston, TX, 77005, USA.
Christine M DiazDepartment of Bioengineering, Rice University, 6100 Main St., MS 142, Houston, TX, 77005, USA.
Seulgi E KimDepartment of Bioengineering, Rice University, 6100 Main St., MS 142, Houston, TX, 77005, USA.
K Jane Grande-AllenDepartment of Bioengineering, Rice University, 6100 Main St., MS 142, Houston, TX, 77005, USA. grande@rice.edu.ORCID http://orcid.org/0000-0003-1533-3767

Funding

American Heart Association 13PRE14110003American Heart Association-American Stroke Association 13PRE14110003National Science Foundation 1450681
6 · The paper itself

Abstract

Functional mitral regurgitation (FMR) is an insidious and poorly understood condition affecting patients with myocardial disease. While current treatments reduce regurgitation, their ability to reverse mitral valve pathology is unclear. We utilized a pseudo-physiological flow loop to study how repair impacted valve composition. Porcine mitral valves were cultured in control geometry (native papillary muscle position and annular area) or high-tension FMR geometry (5 mm apical and 5 mm lateral displacement of papillary muscles, 65% increased annular area) for 2 weeks. To mimic repair, a reversal condition was created by returning one-week FMR conditioned valves to a non-regurgitant geometry and culturing for 1 week. Valve composition and material properties were analyzed. After two-week culture, FMR conditioned tissues were stiffer and stronger than control and underwent extensive fibrotic remodeling, with increased prolyl-4-hydroxylase, lysyl oxidase, matrix metalloproteinase-1, and decorin. The reversal condition displayed a heterogeneous, leaflet- and orientation-dependent response. Reversal-conditioned anterior leaflets and circumferential tissue sections continued to have significant fibrotic remodeling compared to control, whereas reversal-conditioned posterior leaflets, chordae tendineae, and radial tissue sections had significantly decreased remodeling compared to FMR-conditioned tissues. These findings suggest current repairs only partially reverse pathology, underscoring the need for innovation in the treatment of FMR.

Indexed as

AnimalsFibrosisHumansMitral ValveMitral Valve InsufficiencyOrgan Culture TechniquesSwineFunctional mitral regurgitationMitral valve repairOrgan culture

Identifiers

PMID29404848
PMCPMC5897174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.